Morgan Stanley Names Marks & Spencer Top European Retail Pick, Sees Strong Upside 
Telenor to Buy Controlling Stake in Bahnhof in $630 Million Broadband Deal 
OpenAI GPT-5.6 Set for Wider Release After U.S. Commerce Approval, Report Says 
Kitron Q2 Revenue Beats Estimates as Defense Demand Lifts Growth 
Apple Sues OpenAI, Former Employees Over Alleged Trade Secret Theft 
SK Hynix Prices Record U.S. ADR Offering at $149 After $200 Billion Investor Demand 
Zhipu AI Raises HK$31.37 Billion in Discounted Share Sale to Accelerate AI Growth 
Levi Strauss Raises 2026 Outlook After Q2 Earnings Beat, Shares Drop Despite Strong Results 
Chinese Chip Stocks Jump as Apple Reportedly Tests CXMT Memory Chips for China Devices 
Sino Biopharm Stock Rises After AstraZeneca Licensing Deal, GSK Partnership Expansion 
Mizuho’s Top U.S. Industrials Stocks: Why Corteva and Stanley Black & Decker Stand Out 
Bernstein Names IAG, Ryanair as Top European Airline Stocks Ahead of Earnings 
Elon Musk Says Anthropic Leads AI Race as Claude Models Challenge OpenAI 
Nvidia Invests $500M in Firmus Technologies Ahead of Planned ASX IPO 
SK Hynix Soars 13% in Nasdaq Debut After Record $26.5 Billion IPO 
Wolfspeed Sues Navitas Over GaN and SiC Patent Infringement 
OpenAI Executive Fidji Simo to Step Down Amid Health Challenges Ahead of IPO 
VANCOUVER, British Columbia, April 24, 2018 -- via NetworkWire – Sunniva Inc. ("Sunniva" or the “Company") (CSE:SNN) (OTCQX:SNNVF) announced today that it will delay its fourth quarter and year ended December 31, 2017 earnings release and the subsequent earnings call, previously scheduled for April 24, 2018 and April 25, 2018, respectively. The Company now intends to release its results on April 30, 2018, after markets close. The delay is required for the Company’s auditors to complete their final audit procedures.
The Company's executive management will discuss the results during the rescheduled conference call on Tuesday, May 1, 2018 at 11:30 am Eastern Time/8:30 am Pacific Time. To participate in the call, please dial 1-800-319-4610, or (604) 638-5340. An audio replay will be available shortly after the call by dialing 1-855-669-9658 or (604) 674- 8052 and entering access code 5312. The replay will be available for two weeks after the call.
About Sunniva Inc.
Sunniva, through its subsidiaries, is a vertically integrated medical cannabis company operating in the world’s two largest cannabis markets – Canada and California – where we are committed to delivering safe, high-quality products and services at scale. Our vision is to become the lowest cost, highest quality cannabis producer in the markets we serve by building large scale purpose-built current good manufacturing practices greenhouses, offering better quality assurance with cannabis products free from pesticides, providing better patient and doctor access to cannabis education and sourcing better therapeutic delivery devices. Sunniva’s management and board of directors have a proven track record for creating significant shareholder value both in the healthcare and biotech industries.
For more information please visit: www.sunniva.com
Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.
Contact Information:
Dr. Anthony Holler
Chairman and Chief Executive Officer
Investor Relations Contact:
George Jurcic
Manager, Investor Relations
587-430-0680
